CER Groupe
Benoit Moreaux is a seasoned executive with extensive experience in the pharmaceutical and medical device industries. Currently serving as Chief Executive Officer at 4Tissue Laboratory and Head of Operations at AbolerIS Pharma, Benoit holds several board member positions, including with THYMOLUX and CER Groupe. Formerly the Chief Scientific and Technological Officer at BONE THERAPEUTICS S.A., Benoit has demonstrated leadership as General Manager at Quality by Design and COO at Bio-Sourcing. Notably, Benoit founded Nikkiso Belgium, achieving multiple certifications in a brief timeframe and facilitating the global transfer of medical products. Benoit began a career at Baxter International, progressing through various project management roles. Benoit holds a PhD from the University of Liège and is certified as a Project Management Professional (PMP) by PMI.
This person is not in the org chart
This person is not in any teams
CER Groupe
Ideally located within the Walloon Biotech network, CER Groupe provides companies, universities, institutions and individuals with high quality services in life sciences and agriculture. The group offer stands out by providing an end-to-end pre-clinical solution in a regulated environment (ISO, GxP) helping innovative compagnies to incubate, grow and take off in Belgium and abroad. Manufacturer of innovative products, the group delivers pharmaceutical and food industry with polyclonal and monoclonal antibodies, diagnostic kits as well as reagents and colostrum. Recognised for its competencies and high quality level of services, the group contributes to the agricultural economical development supporting the Walloon Region Agriculture Policies and European CAP. Idéalement positionné au sein du réseau biotechnologique wallon, le CER Groupe fournit aux entreprises, institutions, universités et particuliers des services de qualité dans le domaine des sciences du vivant et de l’agriculture. Le groupe se différencie par son offre pré-clinique transversale, exécutée dans un cadre normé (ISO, GxP), permettant d’apporter une réponse complète dans l’accompagnement, l’incubation et la croissance des entreprises innovantes en Belgique et à l’étranger. Producteur de produits innovants, le groupe délivre au secteur pharmaceutique et alimentaire des anticorps polyclonaux et monoclonaux, des kits de diagnostic ainsi que leurs réactifs et du colostrum. Reconnu pour ses compétences et ses services de qualité au secteur agricole, le groupe contribue au développement économique du secteur en support à la Politique Agricole Wallonne et à la PAC Européenne.